Bicocca Open Archive

Logo unimib boa
CONTI, ELISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.614
AS - Asia 5.546
EU - Europa 4.949
SA - Sud America 813
AF - Africa 150
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 15
Totale 22.102
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.078
SG - Singapore 1.876
IT - Italia 1.279
CN - Cina 1.162
VN - Vietnam 895
DE - Germania 804
RU - Federazione Russa 637
HK - Hong Kong 628
BR - Brasile 588
CA - Canada 456
SE - Svezia 447
IE - Irlanda 364
GB - Regno Unito 340
UA - Ucraina 232
IN - India 223
FR - Francia 200
AT - Austria 150
FI - Finlandia 141
BD - Bangladesh 128
TR - Turchia 104
AR - Argentina 84
KR - Corea 82
ID - Indonesia 71
DK - Danimarca 64
JP - Giappone 64
IQ - Iraq 58
PK - Pakistan 51
PL - Polonia 51
ZA - Sudafrica 51
NL - Olanda 48
MX - Messico 45
ES - Italia 44
BE - Belgio 38
PH - Filippine 36
EC - Ecuador 32
CO - Colombia 29
SA - Arabia Saudita 29
VE - Venezuela 28
EG - Egitto 26
UZ - Uzbekistan 24
MA - Marocco 20
CH - Svizzera 17
CL - Cile 17
CZ - Repubblica Ceca 17
AE - Emirati Arabi Uniti 13
EU - Europa 13
IR - Iran 13
LT - Lituania 13
AU - Australia 12
MY - Malesia 12
PE - Perù 11
DZ - Algeria 10
ET - Etiopia 9
HU - Ungheria 9
JO - Giordania 9
RO - Romania 9
TN - Tunisia 9
BO - Bolivia 8
JM - Giamaica 8
KE - Kenya 8
PY - Paraguay 8
AL - Albania 6
AZ - Azerbaigian 6
BH - Bahrain 6
PT - Portogallo 6
TH - Thailandia 6
UY - Uruguay 6
BG - Bulgaria 5
CR - Costa Rica 5
KZ - Kazakistan 5
NP - Nepal 5
OM - Oman 5
PA - Panama 5
PS - Palestinian Territory 5
SK - Slovacchia (Repubblica Slovacca) 5
TW - Taiwan 5
HN - Honduras 4
IL - Israele 4
LV - Lettonia 4
MN - Mongolia 4
NI - Nicaragua 4
SI - Slovenia 4
SN - Senegal 4
TT - Trinidad e Tobago 4
BY - Bielorussia 3
KG - Kirghizistan 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
SY - Repubblica araba siriana 3
GA - Gabon 2
GR - Grecia 2
GT - Guatemala 2
GY - Guiana 2
KH - Cambogia 2
LB - Libano 2
LY - Libia 2
MD - Moldavia 2
RS - Serbia 2
A1 - Anonimo 1
AM - Armenia 1
Totale 22.080
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.175
Singapore 1.148
Ashburn 866
San Jose 663
Hong Kong 600
Chandler 534
Woodbridge 523
Frankfurt am Main 458
Milan 445
Wilmington 377
Dublin 352
Houston 346
Fairfield 298
Ho Chi Minh City 295
Toronto 292
Jacksonville 272
Dearborn 252
New York 248
Dallas 220
Hanoi 205
Los Angeles 201
Santa Clara 189
Beijing 168
Seattle 142
The Dalles 136
Vienna 133
Princeton 130
Chicago 127
Cambridge 109
Nanjing 98
Rome 88
Council Bluffs 85
Shanghai 84
Boardman 74
Buffalo 72
Lauterbourg 72
São Paulo 69
Orem 65
Hefei 64
Seoul 62
Helsinki 53
Jakarta 52
Lachine 51
Guangzhou 48
Moscow 47
Tokyo 47
Munich 46
Columbus 41
London 41
Da Nang 40
Warsaw 40
Chennai 39
Brussels 37
Denver 37
Lawrence 36
Nanchang 33
Atlanta 32
Montreal 32
Brooklyn 31
Haiphong 31
Dong Ket 30
Ottawa 30
Johannesburg 29
Nuremberg 26
Shenyang 26
Pune 25
Baghdad 24
Dhaka 23
Tianjin 23
Fremont 22
Stockholm 22
Altamura 21
Istanbul 21
Phoenix 21
San Diego 21
Biên Hòa 20
Lappeenranta 20
Changsha 19
Tashkent 19
Andover 18
Brasília 18
Falls Church 18
Manchester 18
Mumbai 18
Poplar 18
Rio de Janeiro 18
Amsterdam 17
Carate Brianza 17
Jinan 17
Zhengzhou 17
Belo Horizonte 16
Norwalk 16
Boston 15
Hải Dương 15
Jiaxing 15
Lahore 15
Quito 15
Ankara 14
Busto Arsizio 14
Edmonton 14
Totale 14.336
Salva come PNG Salva come JPEG
Nome #
Increased tissue factor pathway inhibitor and homocysteine in Alzheimer's disease 566
QT interval and dispersion in drug-free anorexia nervosa adolescents: a case control study 500
QTc dispersion and interval changes in drug-free borderline personality disorder adolescents 498
Multifunctional liposomes interact with Abeta in human biological fluids: Therapeutic implications for Alzheimer's disease 460
Serum naturally occurring anti-TDP-43 auto-antibodies are increased in amyotrophic lateral sclerosis 459
Decreased whole-blood global DNA methylation is related to serum hormones in anorexia nervosa adolescents. 453
Irisin and BDNF serum levels and behavioral disturbances in Alzheimer’s disease 439
THE TOXICITY OF AMYLOID-BETA OLIGOMERS AND TAU HYPERPHOSPHORYLATION ARE PREVENTED FROM LIPID-BASED NANOPARTICLES IN HUMAN PRIMARY FIBOBLASTS 433
Serum DBI and biomarkers of neuroinflammation in Alzheimer's disease and delirium 433
Can Signaling Molecules in Fibroblasts Detect Prodromal Alzheimer's Disease? 428
Paradoxical Increase of plasma vitamin B12 and folates with disease severity in anorexia nervosa 427
Anorexia nervosa in adolescent girls and celiac disease serology 401
The one-carbon metabolism in anorexia nervosa of the restrictive type 380
Lipid-based nanoparticles counteract the oligomer abeta toxicity and tau phosphorylation in an ex-vivo biomolecular model of alzheimer disease 374
Behavioural anomalies in neurodegenerative diseases: role of the immune response 373
Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores (Nature Communications, (2021), 12, 1, (3417), 10.1038/s41467-021-22491-8) 372
Donepezil modulates the endogenous immune response: implications for Alzheimer's disease 371
Post-methionine load test: A more sensitive tool to reveal hyperhomocysteinemia in Alzheimer patients? 365
Stavudine Reduces NLRP3 Inflammasome Activation and Modulates Amyloid-β Autophagy 359
Diazepam binding inhibitor and dehydroepiandrosterone sulphate plasma levels in borderline personality disorder adolescents. 356
Riluzole Selective Antioxidant Effects in Cell Models Expressing Amyotrophic Lateral Sclerosis Endophenotypes 354
Beta-amyloid-induced peripheral chemotactic response: what role in Alzheimer’s disease? 341
Peripheral sink effect as possible nanotherapeutic strategy for alzheimer’s disease: an ex vivo study 339
TSPO Modulates Oligomeric Amyloid-β-Induced Monocyte Chemotaxis: Relevance for Neuroinflammation in Alzheimer's Disease 324
Clinical applicability of pCASL as a substitute for FDG-PET in the etiological diagnosis of MCI and SCD: CAPE study protocol 318
Valproate induces epigenetic modifications in lymphomonocytes from epileptic patients 317
Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis 315
Riluzole display glutamate-independent antioxidant properties: relevance for ALS 313
New insights into the genetic etiology of Alzheimer's disease and related dementias 310
Modulation of mapk phosphorylation in fibroblasts from alzheimer patients: erk involvment in glutamate transport and tau hyperphosporylation 303
Increased Soluble APPalpha, Abeta 1-42, and Anti-Abeta 1-42 Antibodies in Plasma From Down Syndrome Patients 298
Multi-pathway blood biomarkers to target and monitor multidimensional prevention of cognitive and functional decline (nested in the IN-TeMPO study framed within the world-wide FINGERS network) 297
Reduced fasting plasma levels of diazepam-binding inhibitor in adolescents with anorexia nervosa 296
Common variants in Alzheimer's disease and risk stratification by polygenic risk scores 295
Blood-based biomarkers of neuroinflammation in alzheimer’s disease: A central role for periphery? 295
Pravastatin acute neuroprotective effects depend on blood brain barrier integrity in experimental cerebral ischemia 290
Beta-amyloid plasma levels in adolescents with anorexia nervosa of the restrictive type 285
Anorexia nervosa of the restrictive type and celiac disease in adolescence 285
Core blood biomarkers of Alzheimer's disease: A single-center real-world performance study 283
Cholinesterase inhibitor use is associated with increased plasma levels of anti-Aβ 1-42 antibodies in Alzheimer's disease patients 280
MAPK phosphorylation in fibroblasts from Alzheimer's disease patients: ERK involvement in EAAT1 expression and modulation with disease severity 280
Lipid-based nanoparticles as a potential tool to deplete abeta. Toward new therapeutic strategies for Alzheimer’s disease? 275
Plasma and cerebrospinal fluid cholesterol esterification is hampered in Alzheimer's disease 273
THE TOXIC EFFECT OF ABETA OLIGOMERS MAY BE REDUCED BY LIPID-BASED NANOPARTICLES IN HUMAN EX-VIVO MODELS 267
Modulation of mapk phosphorylation in fibroblasts from alzheimer’s patients: the erk involvment in ad severity and eaat1 expression 266
Longitudinal effects on plasma abeta levels of imatinib, a gamma-secretase activating protein inhibitor 266
BDNF serum levels with respect to multidimensional assessment in amyotrophic lateral sclerosis 264
Anti-Aβ autoantibodies in the CSF of a patient with CAA-related inflammation: a case report 262
Lipid-based nanoparticles as a potential tool to reduce abeta toxic effect in a human cellular model 259
Erk signalling modulates app metabolism, tau phosphorylation and eaat1 processing in fibroblasts from alzheimer’s patients 253
CLEARANCE OF BETA-AMYLOID OLIGOMERS BY PERIPHERAL MONOCYTES: FURTHER OBSERVATIONS REGARDING THE MODULATORY ROLE OF DONEPEZIL 252
the MonzALS collaborative network 250
Binding of lipid-based nanoparticles to plasma abeta: relevance for new therapeutic strategies in Alzheimer’s disease 242
Myocyte enhancer factor-2D expression in ALS lymphomonocytes 241
Glibenclamide-Loaded Engineered Nanovectors (GNVs) Modulate Autophagy and NLRP3-Inflammasome Activation 235
Anti-Abeta autoantibodies in cerebral amyloid angiopathy related inflammation: a role for pathogenesis? 235
Peripheral sink effect as possible nanotherapeutic strategy for alzheimer’s disease: an ex vivo study 233
Affective states and pathology in adolescents with borderline personality 230
Behavioural Anomalies in Neurodegenerative Diseases: Role of the Immune Response 224
Modulation of MAPK- and PI3/AKT-Dependent Autophagy Signaling by Stavudine (D4T) in PBMC of Alzheimer’s Disease Patients 219
Role of donepezil in influencing endogenous immune response against abeta, an ex vivo and in vitro study 216
Predictors of response to acetylcholinesterase inhibitors in dementia: A systematic review 215
Plasma anti-amyloid-β autoantibodies in all Alzheimer disease types 212
Immune response against beta-amyloid is modulated by acetyl-cholinesterase inhibitors 201
Acetyl-Cholinesterase Inhibitors Modulate The Autoimmune Response Against Beta-Amyloid 197
Serum BDNF in amyotrophic lateral sclerosis decreases with disease severity 195
Novel therapeutic targets in neuropsychiatric disorders: the neuroepigenome 193
Mechanism-free repurposing of drugs for C9orf72-related ALS/FTD using large-scale genomic data 188
Donepezil modulates the endogenous immune response in Alzheimer’s disease, an ex vivo and in vitro study 182
Valproate Treatment in an ALS Patient Carrying a c.194G>A Spastin Mutation and SMN2 Homozygous Deletion 179
Whole-blood global DNA methylation and phenotypic variability in ALS 178
Multicomponent interventions and technologies to reduce the burden of frailty, functional, and cognitive decline: insights from the Age-It Research Program 174
Further ex vivo evidence for a role of donepezil in the modulation of the immune response 174
Whole-blood global DNA methylation is increased in amyotrophic lateral sclerosis independently of age of onset 172
Nilotinib or Dasatinib, but not Imatinib, might reduce Plasma Beta-Amyloid in Leukemia Patients : Implications gor Alzheimer’s Disease 171
ALS genocopy due to co-existence of spastin mutation and SMN2 deletion? A 12 months open label trial with valproic acid 166
Iatrogenic Cerebral Amyloid Angiopathy-Related Inflammation: A Multicenter Case Series 98
Cerebrospinal fluid CEFA composition is enriched in saturated fatty acids and it is altered in Alzheimer's Disease 54
Cardiopulmonary and skeletal muscle strategies underlying exhaustive exercise in adults with glycogen storage disease type III 52
Totale 22.828
Salva come PNG Salva come JPEG
Categoria #
all - tutte 66.159
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.159
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.111 139 145 124 110 71 67 55 50 48 61 85 156
2022/20231.924 192 525 218 207 131 281 36 108 129 25 44 28
2023/20241.311 62 60 71 66 161 323 233 46 59 23 18 189
2024/20253.070 171 277 212 113 238 166 207 141 304 477 263 501
2025/20268.900 1.058 474 665 850 1.123 461 1.387 372 686 833 491 500
2026/202755 55 0 0 0 0 0 0 0 0 0 0 0
Totale 22.828